Bengaluru-based S3V Vascular Technologies has set up an integrated manufacturing facility for developing futuristic medical devices, especially stents and cost-effective products for treatment of heart diseases.
The facility has come up at a cost of Rs 70 crore at Hootgalli Industrial Area in Mysuru.
Interestingly, the Technology Development Board (TDB), under the Union Ministry of Science and Technology, is providing Rs 15-crore support to S3V Vascular Technologies in the effort.
S3V is also launching a new- generation hydrophilic-coated Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter.
Talking about it, the company’s managing director Badari Narayan said, “It is a futuristic product that holds lots of promise. PTCA is a minimally-invasive procedure to open up blocked coronary arteries and allow blood to circulate smoothly to the heart muscle.”
Image Credit : thehindubusinessline.com